Next 10 |
home / stock / ew / ew articles
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.86% on an annualized basis producing an average annual retu...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.47% on an annualized basis producing an average annual retu...
Shares of medical technology company Becton, Dickinson And Company (NYSE:BDX) are trading higher after the company said it will acquire Edwards Lif...
On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competito...
On CNBC's “Mad Money Lightning Round,” Jim Cramer said the new product line of Edwards Lifesciences Corporation (NYSE:EW) is ̶...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 8.25% on an annualized basis producing an average annual retur...
A significant insider transaction involving the exercise of company stock options was reported on February 15, by Catherine Szyman, CVP at Edwards ...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 11.27% on an annualized basis producing an average annual retu...
On Tuesday, February 13, 2024, the FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet regar...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the best interest of the Company to return capital to its shareholders by way of a reduction in st...
Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve p...
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader PR Newswire Combination unlocks new future value-creation opportunities and is expected to be immed...